Nuvalent (NUVL) Gains from Investment Securities (2021 - 2026)

Nuvalent (NUVL) reported Gains from Investment Securities of $7.8 million for Q1 2026, down 33.48% on a YoY basis from $11.8 million in Q1 2025, and up 786.78% quarter-over-quarter from -$1.1 million in Q4 2025.

Nuvalent (NUVL) Gains from Investment Securities (2021 - 2026) Analysis & Trends

Nuvalent has reported Gains from Investment Securities for 6 years, with the latest figure at $7.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Gains from Investment Securities fell 33.48% year-over-year to $7.8 million; the trailing twelve-month figure through Mar 2026 stood at $7.8 million (up 110.14% YoY), and the FY2025 full-year result was $7.7 million, down 3.29% from the prior year.
  • Gains from Investment Securities for Q1 2026 stood at $7.8 million, up from -$1.1 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $11.8 million in Q1 2025, with the low at -$72.6 million in Q4 2024.
  • Historically, Gains from Investment Securities has averaged -$2.5 million across 5 years, with a median of $1.9 million in 2022.
  • The largest YoY upside for Gains from Investment Securities was 322.88% in 2023 against a maximum downside of 357.22% in 2023.
  • Nuvalent's Gains from Investment Securities stood at $6.5 million in 2022, then sank by 357.22% to -$16.6 million in 2023, then sank by 337.35% to -$72.6 million in 2024, then surged by 98.43% to -$1.1 million in 2025, then soared by 786.78% to $7.8 million in 2026.
  • The last three Gains from Investment Securities figures came in at $7.8 million (Q1 2026), -$1.1 million (Q4 2025), and $74418.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Nuvalent 9.70 Bn 9.70 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 7.85 Mn
Mar 31, 2026 7.85 Mn
Dec 31, 2025 -1.14 Mn
Dec 31, 2025 -1.14 Mn
Sep 30, 2025 74,418.00
Sep 30, 2025 74,418.00
Jun 30, 2025 1.22 Mn
Jun 30, 2025 1.22 Mn
Mar 31, 2025 11.80 Mn
Mar 31, 2025 11.80 Mn
Dec 31, 2024 -72.60 Mn
Dec 31, 2024 -72.60 Mn
Sep 30, 2024 150,914.00
Sep 30, 2024 150,914.00
Jun 30, 2024 8.56 Mn
Jun 30, 2024 8.56 Mn
Dec 31, 2023 -16.60 Mn
Dec 31, 2023 -16.60 Mn
Sep 30, 2023 8.50 Mn
Sep 30, 2023 8.50 Mn